investigational immunotherapy

Related by string. * Investigational : Investigational Device Exemption IDE . investigational compound . investigational compounds . Investigational Device Exemption . investigational mTOR inhibitor . investigational oral antiplatelet / immuno therapy . Immunotherapy : allergen immunotherapy . personalized immunotherapy . adoptive immunotherapy . chemo immunotherapy . GVAX immunotherapy * *

Related by context. Frequent words. (Click for all words.) 71 refractory chronic lymphocytic 70 Panzem R 70 Ixempra 69 Pralatrexate 69 multi kinase inhibitor 69 metastatic hormone refractory 68 Receives Orphan Drug Designation 68 castrate resistant prostate cancer 68 forodesine 68 sodium Injection 67 Initiates Phase II 67 Daclizumab 67 Proxinium TM 67 DAVANAT 67 liposomal formulation 67 Gemzar ® 67 OncoVEX GM CSF 66 Irinotecan 66 drug conjugate 66 androgen independent 66 relapsed refractory multiple myeloma 66 metastatic castration resistant 66 GVAX R 66 CYC# 66 Epratuzumab 66 ThermoDox R 66 Lenalidomide 66 GRNVAC1 65 targeting CD# 65 Denufosol 65 Vandetanib 65 luteinizing hormone releasing 65 inhaled formulation 65 personalized immunotherapy 65 Belimumab 65 R sorafenib tablets 65 Meets Primary Endpoint 65 KNS # 65 Sapacitabine 64 humanized monoclonal antibody 64 Traficet EN 64 metastatic castrate resistant 64 Amrubicin 64 lung pancreatic 64 JAK1 64 Myelofibrosis 64 ovarian breast 64 Metastatic Melanoma 64 Lubiprostone 64 Patient Enrollment 64 VALSTAR 64 mTOR inhibitor 64 ixabepilone 64 StromaCel Inc. 64 thymalfasin 64 anticancer compound 64 MKC# 64 humanized anti 64 INCB# [001] 64 NEBIDO R 64 Pivotal Phase III 64 Epidermal Growth Factor Receptor 64 Pirfenidone 64 Phase Ib II 64 Genasense R oblimersen 64 ATL# [001] 64 ALN TTR 64 Golimumab 63 TELINTRA 63 Accentia Biopharmaceuticals 63 Therapeutic Competitors 63 PEG SN# 63 Boceprevir 63 Genasense ® 63 proteasome inhibitor 63 Metabasis Therapeutics 63 Harbor BioSciences 63 immunomodulating 63 Factor VIIa 63 Nexavar ® 63 chemotherapy induced neutropenia 63 Nanobody 63 HuMax CD4 63 poly ADP ribose polymerase 63 Kepivance 63 pertuzumab 63 Zytiga 63 mRCC 63 IMMU 63 HCV protease inhibitor 63 deforolimus 63 REMUNE R 63 Cetrorelix 63 IMC #B 63 HGS ETR2 63 Azedra 63 orally bioavailable 63 Tesetaxel 63 Onalta 63 drug conjugate ADC 63 ongoing Phase 1b

Back to home page